Elizabeth A.R. Garfinkle

This researcher's work focuses on the molecular biology of pediatric leukemias, particularly how a fusion gene called CBFA2T3-GLIS2 disrupts normal gene regulation to drive acute megakaryoblastic leukemia, a rare blood cancer in children. Related work examines other genetic drivers of pediatric acute myeloid and lymphoblastic leukemia, potential drug treatments (such as proteasome inhibitors and navitoclax), and immune-based approaches like identifying leukemia-specific T cells using humanized mouse models. Note: a few unrelated publications about mollusk (bivalve) taxonomy also appear in the record, which are inconsistent with the rest of the profile and may reflect a data or author-matching error.

Publication output was low and steady (about 0-3 papers/year) from 2017-2022, then increased sharply from 2023 onward, though the extremely high counts for 2024-2025 likely reflect large-scale database indexing or co-authorship on large consortium outputs rather than a typical individual research cadence.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026